Patience, patients, and the potential of medical preprints
Patience, patients, and the potential of medical preprints
复制标题
耐心、患者和医学预印本的潜力
DOI：
10.31219/osf.io/e3jgu
复制
发表时间：
2019
期刊：
影响因子：
--
通讯作者：
Patrick S. Phelan
中科院分区：
文献类型：
--
作者：
Patrick S. Phelan
目前关于医学研究预印本优点的争论转向了潜在的好处和危害，通常集中在使临床研究在科学中独一无二的所谓差异上。尽管人们对这一问题的兴趣越来越大，但目前对这一问题的讨论一般都很简短，缺乏对各种考虑和论点的全面评估。在这篇文章中，我试图对医学关于预印本的开放性问题进行彻底的分析，调查现有的问题和主张，确定医学研究与同行不同的特征，并为医学预印本的可能未来提供观点。我的结论是，现存的潜在危害的索赔不支持禁止的建议。尽管如此，医学研究的性质和结果的合理差异，使人们在实施预印本时比在其他科学领域更加谨慎。
Current debate over the merits of preprints for medical research turns on the potential benefits and harms to follow, often centered on purported differences that make clinical research unique among the sciences. Despite growing interest, existing discussions of this issue are generally brief and lack comprehensive appraisal of considerations and arguments. In this essay, I attempt a thorough analysis of the open questions for medicine regarding preprints, surveying existing concerns and claims, identifying what characteristics set medical research apart from its peers, and offering perspective on possible futures for medical preprints. I conclude that the extant claims of potential harms do not support recommendations of prohibition. Despite this, legitimate differences in the character and consequences of medical research give cause for more caution in the implementation of preprints than in other scientific fields.